We are live on ! Find out more
VHAQ.WS

Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share
VHAQ.WS

Delisted

VHAQ.WS was delisted on the 23rd of October, 2023.

32 hedge funds and large institutions have $10.1M invested in Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

14% more funds holding

Funds holding: 2832 (+4)

18% less capital invested

Capital invested by funds: $12.3M → $10.1M (-$2.16M)

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

Holders
32
Holders Change
+4
Holders Change %
+14.29%
% of All Funds
0.56%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
3
Reduced
4
Closed
1
Calls
$1.02M
Puts
Net Calls
+$1.02M
Net Calls Change
+$216K
Name Holding Trade Value Shares
Change
Change in
Stake
VF
26
Virtu Financial
New York
$4K +$5.3K +17,382 New
Wolverine Trading
27
Wolverine Trading
Illinois
$3K +$3.18K +10,444 New
KJHP
28
K.J. Harrison & Partners
Ontario, Canada
$2K
Morgan Stanley
29
Morgan Stanley
New York
$2K
UBS Group
30
UBS Group
Switzerland
$1K +$618 +2,026 New
SGAM
31
Seaport Global Asset Management
New York
$1K +$1.65K +5,400 +245%
Walleye Capital
32
Walleye Capital
New York
$16
PAM
33
Panagora Asset Management
Massachusetts
-$1K -1,826 Closed

VHAQ.WS Hedge Fund Activity: Q3 2021 in Review

32 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share (VHAQ.WS) for Q3 2021, worth a combined $10.1M — down 18% from $12.3M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new VHAQ.WS positions and 1 closed out — a net gain of 4 holders — while 3 added to existing stakes and 4 trimmed.

The largest buyer was K2 Principal Fund, opening a new position worth an estimated $328K. The largest seller was ATW SPAC Management, cutting an estimated $55.7K.

  • 32 institutional investors held Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share (VHAQ.WS) as of Q3 2021, up from 28 in Q2 2021.
  • Funds reported $10.1M of Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share stock for Q3 2021, down 18% quarter-over-quarter.
  • 5 funds opened new Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share positions in Q3 2021 and 1 closed out, a net change of +4 holders.
  • The largest Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share buyer in Q3 2021 was K2 Principal Fund, an estimated $328K added.
  • The largest Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share seller in Q3 2021 was ATW SPAC Management, an estimated $55.7K sold.

Based on aggregated 13F filings for Q3 2021.